To block the renin system or the calcium channel in hypertension -- where do we stand?

Sign In to gain access to subscriptions and/or personal tools.

This Article

	Free Full Text (Free PDF) Free
	Alert me when this article is cited
	Alert me if a correction is posted
	Citation Map

Services

	Email this article to a friend
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new issues of the journal
	Add to Saved Citations
	Download to citation manager
	Request Permissions
	Request Reprints
	Add to My Marked Citations

Citing Articles

	Citing Articles via Google Scholar
	Citing Articles via Scopus

Google Scholar

	Articles by Sever, P. S
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Sever, P. S


Social Bookmarking

	What's this?

To block the renin system or the calcium channel in hypertension — where do we stand?

Peter S Sever

Department of Clinical Pharmacology, Imperial College School of Medicine, NHLI Division, St Mary's Hospital, London, UK, p.sever{at}ic.ac.uk

Key Words: angiotensin-converting enzyme • angiotensin II • aldosterone • fibrosis • transforming growth factor-beta

References

Blood Pressure Lowering Treatment Trialists Collaboration. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs; results of prospectively designed overviews of randomised trials. Lancet 2000; 355:1955-64.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]

MacMahon S., Rodgers A. The Effects of antihypertensive treatment on vascular disease: reappraisal of the evidence in 1994. J Vasc Med Biol 1993; 4:265-71.

MacMahon S., Peto R., Cutler J. et al. Blood pressure, stroke, and coronary heart disease. Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990; 335: 765-74.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]

Medical Research Council Working Party. MRC trial of treatment of mild hypertension: principal results. BMJ 1985; 291:97-104.[Abstract/Free Full Text]

Veterans Administrative Cooperative Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension; results in patients with diastolic blood pressures averaging 115 through 129 mmHg. JAMA 1967; 202: 116-22.[Abstract/Free Full Text]

Veterans Administrative Cooperative Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension: results in patients with diastolic blood pressures averaging 90 through 114 mmHg.JAMA 1970; 213: 1143-52.[Abstract/Free Full Text]

Staessen J.,Fagard R.,Thijs L. et al. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. Lancet 1997; 350: 757-64.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]

Sever P. ACE inhibitors in hypertension: still a shortage of evidence. JRAAS 2000; 1: 117-8.[Medline] [Order article via Infotrieve]

HOPE (Heart Outcomes Prevention Evaluation) study investigators. effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med 2000; 342: 145-53.[Abstract/Free Full Text]

Williams B. The renin-angiotensin-system and cardiovascular disease: hope or hype? JRAAS 2000; 1: 142-6.[Medline] [Order article via Infotrieve]

Brown M., Palmer C., Castaigne A. et al. Morbidity and mortality in patients randomised to double-blind treatment with a long-Acting calcium channel blocker or diuretic in the International Nifedipine GITS Study: Intervention as a goal in hypertension treatment (INSIGHT). Lancet 2000; 356: 366-72.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]

Hansson L., Lindholm L., EkbomT. et al. Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity. The Swedish Trial in Old Patients With Hypertension-2 Study. Lancet 1999; 354: 1751-6.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]

Hannson L., Hedner T., Lund-Johansen P. et al. Randomised trial of effects of calcium antagonists compared with diuretics snd β-Blockers on cardiovascular morbidity and mortality in hypertension: The Nordic Diltiazem (NORDIL) study. Lancet 2000; 356: 359-65.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]

Hannson K., Lindholm L., Niskanen L. et al. Effect of angiotensin-converting enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: The Captopril Prevention Project (CAPPP) Randomised Trial. Lancet 1999; 353: 611-6.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]

Davis BR, Cutler JA, Gordon DJ et al. Rationale and design for the Antihypertensive and Lipid Lowering treatment to prevent Heart Attack Trial (ALLHAT). Am J Hypertens 1996;9:34260.

Dahlof B., Sever PS, Poulter NR, Wedel H. On behalf of the ASCOT Steering Committee. International Society of Hypertension 1998. J Hypertens 1998; 16 (Suppl 2): S212.

World Health Organisation-International Society of Hypertension Blood Pressure Lowering Treatment Trialist's Collaboration. Protocol For prospective collaborative overviews of major randomised trials of blood-pressure lowering treatments. J Hypertens 1998; 16: 127-37.[Web of Science][Medline] [Order article via Infotrieve]

Estacio R., Jeffers B., Hiatt W., Biggerstaff S., Gifford N., Schrier R. The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin dependant diabetes and hypertension. N Engl J Med 1998; 338:645-52.[Abstract/Free Full Text]

Rafflenbeul W. Prognostic Benefits of anti hypertensive therapy: concern about another `solid` matter-analysis. Br J Cardiol 2000; 7: 703-8.

Pahor M., Psaty BM, Alderman MH et al. Health outcomes associated with calcium antagonists compared with other first-line anti hypertensive therapies.A meta analysis of randomised controlled trials. Lancet 2000; 356: 1949-54.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]

He J., Whelton PK Selection of initial anti hypertensive drug therapy. Lancet 2000; 356:1942-3.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]